Beneficial Effects of Slow-Release Large Neutral Amino Acids after a Phenylalanine Oral Load in Patients with Phenylketonuria

The mainstay of phenylketonuria treatment is a low protein diet, supplemented with phenylalanine (Phe)-free protein substitutes and micronutrients. Adhering to this diet is challenging, and even patients with good metabolic control who follow the dietary prescriptions in everyday life ignore the rec...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Iris Scala, Daniela Concolino, Anna Nastasi, Giulia Esposito, Daniela Crisci, Simona Sestito, Stefania Ferraro, Lucia Albano, Margherita Ruoppolo, Giancarlo Parenti, Pietro Strisciuglio
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
PKU
Acceso en línea:https://doaj.org/article/aa982d4c67f24c4ca624e5e7b6b14a3c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:aa982d4c67f24c4ca624e5e7b6b14a3c
record_format dspace
spelling oai:doaj.org-article:aa982d4c67f24c4ca624e5e7b6b14a3c2021-11-25T18:36:06ZBeneficial Effects of Slow-Release Large Neutral Amino Acids after a Phenylalanine Oral Load in Patients with Phenylketonuria10.3390/nu131140122072-6643https://doaj.org/article/aa982d4c67f24c4ca624e5e7b6b14a3c2021-11-01T00:00:00Zhttps://www.mdpi.com/2072-6643/13/11/4012https://doaj.org/toc/2072-6643The mainstay of phenylketonuria treatment is a low protein diet, supplemented with phenylalanine (Phe)-free protein substitutes and micronutrients. Adhering to this diet is challenging, and even patients with good metabolic control who follow the dietary prescriptions in everyday life ignore the recommendations occasionally. The present study explores the ability of slow-release large neutral amino acids (srLNAAs) to prevent Phe increase following a Phe dietary load. Fourteen phenylketonuric patients aged ≥13 years were enrolled in a 6-week protocol. Oral acute Phe loads of 250 and 500 mg were added to the evening meal together with srLNAAs (0.5 gr/kg). Phe and tyrosine were dosed before dinner, 2h-after dinner, and after the overnight fast. After oral Phe loads, mean plasma Phe remained stable and below 600 µmol/L. No Phe peaks were registered. Tyrosine levels significantly increased, and Phe/Tyrosine ratio decreased. No adverse events were registered. In conclusion, a single oral administration of srLNAAs at the dose of 0.5 gr/kg is effective in maintaining stable plasma Phe during acute oral loads with Phe-containing food and may be added to the dietetic scheme in situations in which patients with generally good adherence to diet foresee a higher than prescribed Phe intake due to their commitments.Iris ScalaDaniela ConcolinoAnna NastasiGiulia EspositoDaniela CrisciSimona SestitoStefania FerraroLucia AlbanoMargherita RuoppoloGiancarlo ParentiPietro StrisciuglioMDPI AGarticlephenylketonurialarge neutral amino acidsphenylalaninetyrosinePKULNAANutrition. Foods and food supplyTX341-641ENNutrients, Vol 13, Iss 4012, p 4012 (2021)
institution DOAJ
collection DOAJ
language EN
topic phenylketonuria
large neutral amino acids
phenylalanine
tyrosine
PKU
LNAA
Nutrition. Foods and food supply
TX341-641
spellingShingle phenylketonuria
large neutral amino acids
phenylalanine
tyrosine
PKU
LNAA
Nutrition. Foods and food supply
TX341-641
Iris Scala
Daniela Concolino
Anna Nastasi
Giulia Esposito
Daniela Crisci
Simona Sestito
Stefania Ferraro
Lucia Albano
Margherita Ruoppolo
Giancarlo Parenti
Pietro Strisciuglio
Beneficial Effects of Slow-Release Large Neutral Amino Acids after a Phenylalanine Oral Load in Patients with Phenylketonuria
description The mainstay of phenylketonuria treatment is a low protein diet, supplemented with phenylalanine (Phe)-free protein substitutes and micronutrients. Adhering to this diet is challenging, and even patients with good metabolic control who follow the dietary prescriptions in everyday life ignore the recommendations occasionally. The present study explores the ability of slow-release large neutral amino acids (srLNAAs) to prevent Phe increase following a Phe dietary load. Fourteen phenylketonuric patients aged ≥13 years were enrolled in a 6-week protocol. Oral acute Phe loads of 250 and 500 mg were added to the evening meal together with srLNAAs (0.5 gr/kg). Phe and tyrosine were dosed before dinner, 2h-after dinner, and after the overnight fast. After oral Phe loads, mean plasma Phe remained stable and below 600 µmol/L. No Phe peaks were registered. Tyrosine levels significantly increased, and Phe/Tyrosine ratio decreased. No adverse events were registered. In conclusion, a single oral administration of srLNAAs at the dose of 0.5 gr/kg is effective in maintaining stable plasma Phe during acute oral loads with Phe-containing food and may be added to the dietetic scheme in situations in which patients with generally good adherence to diet foresee a higher than prescribed Phe intake due to their commitments.
format article
author Iris Scala
Daniela Concolino
Anna Nastasi
Giulia Esposito
Daniela Crisci
Simona Sestito
Stefania Ferraro
Lucia Albano
Margherita Ruoppolo
Giancarlo Parenti
Pietro Strisciuglio
author_facet Iris Scala
Daniela Concolino
Anna Nastasi
Giulia Esposito
Daniela Crisci
Simona Sestito
Stefania Ferraro
Lucia Albano
Margherita Ruoppolo
Giancarlo Parenti
Pietro Strisciuglio
author_sort Iris Scala
title Beneficial Effects of Slow-Release Large Neutral Amino Acids after a Phenylalanine Oral Load in Patients with Phenylketonuria
title_short Beneficial Effects of Slow-Release Large Neutral Amino Acids after a Phenylalanine Oral Load in Patients with Phenylketonuria
title_full Beneficial Effects of Slow-Release Large Neutral Amino Acids after a Phenylalanine Oral Load in Patients with Phenylketonuria
title_fullStr Beneficial Effects of Slow-Release Large Neutral Amino Acids after a Phenylalanine Oral Load in Patients with Phenylketonuria
title_full_unstemmed Beneficial Effects of Slow-Release Large Neutral Amino Acids after a Phenylalanine Oral Load in Patients with Phenylketonuria
title_sort beneficial effects of slow-release large neutral amino acids after a phenylalanine oral load in patients with phenylketonuria
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/aa982d4c67f24c4ca624e5e7b6b14a3c
work_keys_str_mv AT irisscala beneficialeffectsofslowreleaselargeneutralaminoacidsafteraphenylalanineoralloadinpatientswithphenylketonuria
AT danielaconcolino beneficialeffectsofslowreleaselargeneutralaminoacidsafteraphenylalanineoralloadinpatientswithphenylketonuria
AT annanastasi beneficialeffectsofslowreleaselargeneutralaminoacidsafteraphenylalanineoralloadinpatientswithphenylketonuria
AT giuliaesposito beneficialeffectsofslowreleaselargeneutralaminoacidsafteraphenylalanineoralloadinpatientswithphenylketonuria
AT danielacrisci beneficialeffectsofslowreleaselargeneutralaminoacidsafteraphenylalanineoralloadinpatientswithphenylketonuria
AT simonasestito beneficialeffectsofslowreleaselargeneutralaminoacidsafteraphenylalanineoralloadinpatientswithphenylketonuria
AT stefaniaferraro beneficialeffectsofslowreleaselargeneutralaminoacidsafteraphenylalanineoralloadinpatientswithphenylketonuria
AT luciaalbano beneficialeffectsofslowreleaselargeneutralaminoacidsafteraphenylalanineoralloadinpatientswithphenylketonuria
AT margheritaruoppolo beneficialeffectsofslowreleaselargeneutralaminoacidsafteraphenylalanineoralloadinpatientswithphenylketonuria
AT giancarloparenti beneficialeffectsofslowreleaselargeneutralaminoacidsafteraphenylalanineoralloadinpatientswithphenylketonuria
AT pietrostrisciuglio beneficialeffectsofslowreleaselargeneutralaminoacidsafteraphenylalanineoralloadinpatientswithphenylketonuria
_version_ 1718410910499864576